HCPCS Level IIdrugActive
J9229
Inj inotuzumab ozogam 0.1 mg
BETOS: O1E
Effective: 2019-01-01
Description
Injection, inotuzumab ozogamicin, 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Besponsa
Manufacturer
Pfizer Inc
HCPCS Dosage
0.1 MG
Billing Units
9.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.